Makriyannis, Alexandros
F. Hoffmann-La Roche AG · University of Bern · Northeastern University · University of California, Irvine · University of L'Aquila · Université Laval
19 papers on CoChatORCID 0000-0003-3272-3687
Most cited papers
- Verified
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research
Cited by 1,470
- Verified
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research
Cited by 813
- Verified
CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 521
- Verified
Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 491
- Verified
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
Sadybekov, A. A., Sadybekov, A. V., Liu, Y., Iliopoulos-Tsoutsouvas, C., Huang, X.-P., Pickett, J., Houser, B., Patel, N., Tran, N. K., Tong, F., et al. (2022) · Nature
Computational Drug Discovery MethodsChemical Synthesis and Analysis
Cited by 417
- Verified
CB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 391
- Verified
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., et al. (2013) · Molecular Psychiatry
Cannabis and Cannabinoid ResearchMemory and Neural Mechanisms
Cited by 307
- Verified
123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors
Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology
Cannabis and Cannabinoid ResearchRadiopharmaceutical Chemistry and Applications
Cited by 252
- Verified
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research
Cited by 230
- Verified
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research
Cited by 183
- Verified
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
Rahn, E. J., Makriyannis, A., & Hohmann, A. G. (2007) · British Journal of Pharmacology
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 146
- Verified
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., & Hohmann, A. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 116
- Verified
Large Receptor Reserve for Cannabinoid Actions in the Central Nervous System
Gifford, A. N., Bruneus, M., Gatley, S. J., Lan, R., Makriyannis, A., & Volkow, N. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology Research
Cited by 100
- Verified
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
Godlewski, G., Alapafuja, S. O., Bátkai, S., Nikas, S. P., Cinar, R., Offertáler, L., Osei-Hyiaman, D., Liu, J., Mukhopadhyay, B., Harvey-White, J., et al. (2010) · Chemistry & Biology
Cannabis and Cannabinoid ResearchEicosanoids and Hypertension Pharmacology
Cited by 95
- Verified
The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy
Deng, L., Guindon, J., Vemuri, V. K., Thakur, G. A., White, F. A., Makriyannis, A., & Hohmann, A. G. (2012) · Molecular Pain
Pain Mechanisms and TreatmentsCancer Treatment and Pharmacology
Cited by 94
- Verified
The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Gueye, A. B., Pryslawsky, Y., Trigo, J. M., Poulia, N., Delis, F., Antoniou, K., Loureiro, M., Laviolette, S. R., Vemuri, K., Makriyannis, A., et al. (2016) · International Journal of Neuropsychopharmacology
Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study
Cited by 74
- Verified
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler, C. W., Redhi, G. H., Vemuri, K., Makriyannis, A., Le Foll, B., Bergman, J., Goldberg, S. R., & Justinova, Z. (2016) · Neuropsychopharmacology
Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior
Cited by 73
- Verified
Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters
Wood, J. T., Williams, J. S., Pandarinathan, L., Courville, A., Keplinger, M. R., Janero, D. R., Vouros, P., Makriyannis, A., & Lammi-Keefe, C. J. (2008) · Clinical Chemistry and Laboratory Medicine
Cannabis and Cannabinoid ResearchClinical Laboratory Practices and Quality Control
Cited by 71
- Verified
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats
Wills, K. L., Vemuri, K., Kalmar, A., Lee, A., Limebeer, C. L., Makriyannis, A., & Parker, L. A. (2014) · Psychopharmacology
Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free